Topic: Implantables

It’s been four months since Geoff Martha took over the corner office at Medtronic (NYSE:MDT), and […]

Garwood Medical Devices announced today that it raised $4 million in a Series C financing round […]

The Centers for Medicare & Medicaid Services (CMS) announced updated guidance urging for the resumption […]

IlluminOss Medical today said it received expanded FDA 510(k) clearance for its Photodynamic Bone Stabilization […]

Medtronic has announced that its recently US Food and Drug Administration (FDA)-approved InterStim Micro neurostimulator […]

Dive Brief: Demand for Sientra’s breast implant products recovered swiftly in its second quarter, causing […]

Spinal disorder treatment developer Life Spine announced that it received FDA clearance for its Plateau-A Ti anterior […]

The orthopedic company known for its customized knee implants now plans to sell a standard off-the-shelf knee in […]

Endologix, based in Irvine, California, won clearance in the European Union for its ALTO Abdominal […]

Two-year results of Axonics’ ARTISAN-sacral neuromodulation (SNM) study demonstrate that patients implanted with the r-SNM […]

WishBone Medical announced today that it entered into a national agreement with Vizient to provide orthopedic implants to […]

Abbott Laboratories’s most recent FDA nod will allow the use of the company’s Patient Controller […]

FX Shoulder USA announced today that the FDA issued 510(k) clearance for a new version […]

Staar Surgical (NSDQ:STAA) announced today that it received CE Mark approval for its EVO Viva presbyiopia-correcting […]

Joint replacement implant maker Conformis (NSDQ:CFMS) said today that it anticipates a COVID-19-influenced 50% year-over-year drop in […]

WHITE BEAR LAKE, Minn.–(BUSINESS WIRE)–Envoy Medical® Corporation, a hearing health company focused on providing innovative […]

Dive Brief: An editorial published in the July 7 issue of the Journal of the […]

Axonics, a company that has developed and is commercialising novel implantable sacral neuromodulation (SNM) devices […]

Boston Scientific has announced winning FDA clearance for its LUX-Dx Insertable Cardiac Monitor (ICM), an […]

Xenco Medical this week said it launched its Cancellex porous titanium lumbar interbodies. The injection-molded […]

Intact Vascular is reporting positive results from a clinical trial of its below-the-knee vascular implant […]

GTX Medical, a medtech company with offices in The Netherlands and Switzerland, has announced that it received […]

The FDA has approved Medtronic’s latest deep-brain stimulation implant, featuring the ability to read, capture […]

SeaSpine has announced the limited commercial launches and completion of initial surgeries of both its […]

June 22, 2020 06:00 UTC U.S. commercialization expected to begin in the first half of […]

Smith & Nephew (NYSE:SNN) announced today that its Regeneten bioinductive implant for rotator cuff procedures received […]

CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of […]

4WEB Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to […]

Researchers at Rice University have developed an implantable neural stimulator that is both wireless and […]

Axonics, a company that has developed implantable sacral neuromodulation (SNM) devices for the treatment of […]

Stanford spin-out Fibralign announced today that it entered into a long-term distributor agreement with Terumo for the BioBridge collagen […]

Abiomed (NSDQ:ABMD) announced that it received FDA emergency use authorization (EUA) for its Impella RP for […]

Conventus Orthopaedics announced today that it acquired single-use, sterile-packaged implant and instrument kit maker Flower Orthopedics. Flower […]

Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of […]

Pulmonx has raised $66 million in a financing round despite a lull in procedures and […]

Second Sight Medical (NSDQ:EYES) announced that it priced an underwritten public offering with expected gross proceeds […]

Dive Brief: Boston Scientific’s organic sales declined 2.9% during the first quarter as health systems […]

Second Sight Medical Products provided an update on its strategic options and gave some clarity […]

  Despite the COVID-19 pandemic, medical device companies are still working to gain regulatory approvals […]